ARTICLE | Clinical News
NeoTherapeutics to begin Phase II Neotrofin trial
February 5, 2001 8:00 AM UTC
NEOT said it will begin next quarter a 12-week U.S. Phase II trial using high doses of its Neotrofin small molecule nerve growth stimulator in 450 patients with Alzheimer's disease (AD). NEOT said the...